Dr. Debi Bhattacharya wins the prestigious RPS-PRUK Research Award

Pharmacy Research UK (PRUK) is delighted to award the prestigious PRUK-sponsored Royal Pharmaceutical Society (RPS) Pharmacy Practice Research award to Dr. Debi Bhattacharya. The award is intended to recognise individuals who have made a significant contribution to the field of pharmacy research and have potential to be a leader in the field.
Dr. Bhattacharya is a Senior Lecturer in Pharmacy Practice at the University of East Anglia School of Pharmacy, the Chair of the East Anglia Local Practice Forum and holds a certificate in Higher Education Practice.
As part of the award, Dr. Bhattacharya will be giving a lecture at the Royal Pharmaceutical Society conference on the 4th September (2). Her lecture will be titled “Medication adherence interventions; questioning the paradigm and proposing a new way forward”. It will provide background and pharmacy context relating to medication non-adherence, summarising the evidence for barriers to medication adherence and the interventions to address these barriers through reference to her own research. Asked about her experience, Dr. Bhattacharya said:

“Research success is underpinned by excellence of the team; I would like to take this opportunity to thank my research students, colleagues, and patient and public representatives who have worked with me to deliver high quality research. As an academic I feel that I get to have my cake and eat it. I am privileged to have a job that supports me to learn, be creative, question the paradigm and potentially make a difference to society. To get recognition for doing something that I passionately enjoy really is the icing on top of that cake.”

This promises to be a fascinating and highly relevant talk and we encourage pharmacists and pharmacy researchers at all stages of their career to attend.
PRUK will also be running a satellite session at the RPS conference on “Where do you fall into the unlicensed medicines trap? The challenges of unlicensed medicines” in conjunction with the RPS and the UK Clinical Pharmacy Association (UKCPA) (3). The workshop will be led by Gemma Donovan and Lindsay Parkin from the EMULSION study team (4) at the University of Sunderland. Medicines that are unlicensed fall into the ‘no man’s land’ of medicines regulation and safety, and subsequently many of the processes and governance arrangements that we take for granted for licensed medicines simply do not exist. Findings from the UKCPA-PRUK EMULSION study have highlighted many challenges associated with unlicensed medicines use across primary and secondary care. This creates problems for prescribers, pharmacists and patients when trying to use these medicines. The interactive session will be useful for pharmacists at all stages of their career and across all care settings.
For more information please contact Kate Woode at kate.woode@rpharms.com.

1) PRUK is the principle funder of pharmacy research in the UK. Founded as a result of a merger in 2012 of two previous research funding charities, PRUK has a broad programme of research in place. PRUK funds both research projects and research fellowships to improve skills across the Pharmacy sector. Registered charity number 1148335.
2) The Royal Pharmaceutical Society Conference will be held on Sunday 4th September and Monday 5th September at the International Convention Centre in Birmingham. For more information see http://www.rpharms.com/rps-annual-conference/rps-conference-2016.asp.
3) The UKCPA is a not-for-profit member organisation for pharmacists, technicians and health care professionals who provide clinical pharmacy services to patients. It promotes expert practice in medicines management and strives to foster and support excellence in clinical pharmacy practice in order for practitioners to provide outstanding patient care. For more information see http://www.ukcpa.net/.
4) EMULSION stands for Exploring Multidisciplinary use of UnLicenSed medicines In primary and secONdary care. For more information see http://wp.sunderland.ac.uk/emulsionstudy/.

Subscribe for updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Leave a Reply